POASNYSEIndustrial Instruments For Measurement, Display, and ControlUS GAAP · USD

Phaos Technology Holdings (Cayman) Limited

PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd is a Cayman Islands holding company with operating headquarters in Singapore. Through its subsidiaries, it develops and sells advanced microscopy solutions used for high-precision imaging and measurement applications.

Revenue0.1m USD
−21.2 %y/y
Operating profit (EBIT)-6.2m USD
−17.7 %y/y
EBIT margin-4,706.8%
−1,558.5 ppy/y
Net income-6.2m USD
−19.9 %y/y
Free cash flow-10.9m USD
−181.0 %y/y

Fiscal year 2026 · change from previous year

Development 2024–2026

-8-6-4-202m USD2024: 1.9 m USD2024: EBIT -2.5 m USD20242025: 0.17 m USD2025: EBIT -5.3 m USD20252026: 0.13 m USD2026: EBIT -6.2 m USD20260.13-6.2
RevenueOperating profit (EBIT)

Business

Share of revenue
Microscopy systems55 %

High-precision microscopy instruments for imaging and analysis.

Imaging software and workflows20 %

Software used to capture, process, and analyze microscopy data.

Measurement and inspection solutions15 %

Instrument-based solutions for dimensional and visual inspection tasks.

Service and support10 %

Installation, maintenance, training, and technical support for customers.

Customers

The company sells microscopy solutions to organizations that need precise imaging, measurement, and inspection capability. Its buyers are typically research, laboratory, and industrial users that value resolution, repeatability, and application support. Demand is tied to customers that use microscopy in scientific, quality-control, or advanced inspection workflows.

Research and academic users

Buy microscopy platforms for scientific imaging, experimentation, and publication-grade analysis.

Industrial inspection customers

Buy instruments for quality control, failure analysis, and precision measurement.

Laboratory and technical facilities

Buy systems and software for routine imaging and measurement workflows.

Channel and institutional buyers

Buy through institutional purchasing processes or local sales partners for deployment support.

Strategy

The company’s priorities appear centered on building a focused advanced microscopy platform, supporting customers through specialized products and services, and maintaining governance and disclosure standards expected of a U.S.-listed foreign issuer. Its equity incentive plan suggests an emphasis on retaining technical and managerial talent in a specialized instrumentation business. The available reports do not provide a detailed operating roadmap or regional expansion plan.

Expand the microscopy product platformMedium term

A specialized instrumentation business depends on differentiated performance and application fit.

Retain technical talentShort term

Product development and customer support depend on specialized personnel.

Maintain governance and reporting qualityShort term

U.S. listing and foreign-issuer status require consistent disclosure and controls.

Geography

The company is headquartered in Singapore and organized as a Cayman Islands holding company, giving it an international corporate structure with operating presence in Asia. Public filings identify Singapore as the principal executive location, while its securities trade in the United States on NYSE American. The available reports do not disclose a formal revenue-by-country split.

Risks

The business depends on specialized product demand, technical differentiation, and effective execution in a niche instrumentation market. Public filings also highlight governance and audit-related matters, which are especially important for a foreign private issuer with a U.S. listing. Like other industrial instrument makers, it faces risks from customer concentration, product acceptance, and the need to keep pace with technology requirements.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Dependence on specialized microscopy demand1Product and technology obsolescence2Audit and internal control risk3Governance and related-party scrutiny4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Dependence on specialized microscopy demandImpact: HighLikelihood: Medium

    A narrow product set can make revenue sensitive to customer buying cycles and adoption rates.

    Exposure: Advanced microscopy and inspection customers

  2. Product and technology obsolescenceImpact: HighLikelihood: Medium

    Instrument makers must keep pace with imaging performance and workflow needs.

    Exposure: Microscopy platforms and software

  3. Audit and internal control riskImpact: HighLikelihood: Medium

    Auditor changes and prior going-concern language can raise questions about reporting robustness.

    Exposure: Financial reporting and controls

  4. Governance and related-party scrutinyImpact: MediumLikelihood: Medium

    Foreign issuers face heightened investor and regulatory attention on control and disclosure matters.

    Exposure: Corporate governance and related-party relationships

Ask Clarifo about Phaos Technology Holdings (Cayman) Limited

Accounting

Judgemental items
Revenue recognition

Microscopy systems may include equipment, software, installation, and support elements with different timing.

Impact: Can shift revenue between delivery dates and service periods.

Warranty and service provisions

Instrument businesses often need estimates for post-sale obligations and repairs.

Impact: Affects gross margin and liability balances.

Equity compensation

The 2026 equity incentive plan creates share-based compensation expense.

Impact: Impacts operating expenses and diluted share count.

Going-concern assessment

Prior auditor language referenced going-concern uncertainty in the historical financial statements.

Impact: Can influence disclosures, valuation, and investor perception.

Publicly listed companies with a comparable business focus.

Last updated: 28/09/2026